Date: 2015-01-09 11:56:08

Biotechnology

HER2/neu

Ribbon symbolism

Immunology

Pertuzumab

Trastuzumab

Targeted therapy

Breast cancer

Bispecific monoclonal antibody

Monoclonal antibodies

Medicine

Biology

F-star Announces Initiation of a Phase 1 Clinical Trial for FS102 for the Treatment of HER2-Positive Breast and Gastric Cancer CAMBRIDGE, UK – 9 JanuaryF-star, a biopharmaceutical company focused on oncology and

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 96,50 KB